A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
Condition: Migraine Interventions: Drug: Lasmiditan; Drug: Placebo Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials